Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/29/2007US20070072906 Pyrrole compounds
03/29/2007US20070072905 Novel process for preparing dopenzil and its derivatives
03/29/2007US20070072904 1-arylsulfone-substituted indole carboxylic acids or amides; peroxisome proliferator-activated receptor PPAR modulators; obesity, diabetes, cardiovascular disorders
03/29/2007US20070072903 Altering the concentration of intracellular agents by p2x7 receptor modulation
03/29/2007US20070072902 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
03/29/2007US20070072901 1-Amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5
03/29/2007US20070072900 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
03/29/2007US20070072899 Method for treating drug and behavioral addictions
03/29/2007US20070072898 MAP KAP-K2 inhibitory activity; for treating inflammatory injury, autoimmune diseases, asteropathia destruens, cancer and/or growth of tumors
03/29/2007US20070072897 1-[5-(benzyloxy)-1H-indol-1-yl]-3-(methylamino)-1-phenylpropan-2-ol;fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
03/29/2007US20070072896 Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation
03/29/2007US20070072895 Polymorphs of 1-cyclopropyl-7-([s,s])-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro -8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
03/29/2007US20070072894 Synthesis of pyrroloquinoline quinone (PQQ)
03/29/2007US20070072893 Substituted imidazo ring systems and methods
03/29/2007US20070072892 [3H]-(S,S)-2,2-dimethyl-5-(6-phenyl-pyridazin-3-yl)-5-aza-2-azonia-bicyclo[2.2.1]heptane, iodide; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, mild cognitive impairment, age-associated memory impairment
03/29/2007US20070072891 Method for the Protection Against the Risk of Cardiac Disorders Comprising Administration of Tiotropium Salts
03/29/2007US20070072890 Novel crystal forms of irinotecan hydrochloride
03/29/2007US20070072889 Hydrocodone polymorphs
03/29/2007US20070072888 Indol-3-yl-carbonyl-azaspiro derivatives
03/29/2007US20070072887 Spirofuropyridine aryl derivatives
03/29/2007US20070072886 Method of treating movement disorders using barbituric acid derivatives
03/29/2007US20070072885 Bicyclic derivatives for the treatment of abnormal cell growth
03/29/2007US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide
03/29/2007US20070072882 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/29/2007US20070072881 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/29/2007US20070072880 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/29/2007US20070072879 Novel compounds as metabotropic glutamate receptor antagonists
03/29/2007US20070072878 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2-[5(6)-Amidino-2-benzimidazoyl]-5-(4-nitrophenyl)furan
03/29/2007US20070072877 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2,5-Bis(2-methyl-4-N,N'-di-BOCguanidinophenyl)furan
03/29/2007US20070072876 Novel pyrimidine carboxamides
03/29/2007US20070072875 Anti-inflammatory compositions and methods of use
03/29/2007US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors
03/29/2007US20070072873 Novel thiophene derivatives which are HM74A agonists
03/29/2007US20070072872 Treating sexual desire disorders with flibanserin
03/29/2007US20070072871 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
03/29/2007US20070072870 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
03/29/2007US20070072869 CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS
03/29/2007US20070072868 Novel synthesis of gatifloxacin
03/29/2007US20070072867 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-YL)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5amine
03/29/2007US20070072866 that inhibit the metabolic activity of the enzyme glycogen synthase kinase 3 beta (GSK-3 beta), which is believed to cause the neurodegeneration that results in diseases of the central nervous system; enzyme inhibitors
03/29/2007US20070072865 Bicyclic piperazine compound and use thereof
03/29/2007US20070072864 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists
03/29/2007US20070072863 thieno [2,3-b: 5,4-c'] dipyridine derivatives, used as as selective metabotropic glutamate receptor 1 (mGluR1) antagonists, for the treatment of pain, headaches, anxiety, incontinence and neurodegenerative diseases such as Alzheimer's disease
03/29/2007US20070072862 Bis-aryl amide compounds and methods of use
03/29/2007US20070072861 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
03/29/2007US20070072860 Apoptosis promoters
03/29/2007US20070072859 Pharmaceutical compounds
03/29/2007US20070072858 activating 4-chlorophenylacetic acid. with a carboxylic acid activating reagent a thionyl halide in a compatible solvent (1,2- dichloromethane), bromonating the intermediated with bromine, esterifying with a chiral alcohol
03/29/2007US20070072857 Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot
03/29/2007US20070072856 inhibitors of lysophosphatidic acid acyltransferase beta (LPAAT- beta ) activity; cancer screening therapy
03/29/2007US20070072855 5-(5-Chloro-2,4-dihydroxy-phenyl)-4-(4-methoxy-phenyl)-2H-pyrazole-3-carboxylic acid, for example; for treatment of diseases which are mediated by excessive or inappropriate HSP90 activity, such as cancers
03/29/2007US20070072854 such as 6-(nitrooxy)hexanoic acid 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol hydrochloride; adrenergic blocking agents; for treatment of hypertension, cardiovascular diseases, glaucoma, migraine headache and vascular diseases
03/29/2007US20070072853 Benzimidazole derivatives compositions containing them, preparation thereof and uses thereof
03/29/2007US20070072852 Heterocyclic aspartyl protease inhibitors
03/29/2007US20070072851 Pyrazolopyridine and pyrazolopyrimidine compounds
03/29/2007US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
03/29/2007US20070072848 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic
03/29/2007US20070072847 -(4-Hydroxy-3,5-dimethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; headaches; non-insulin dependent diabetes; antidiabetic agents; cardiovascular/nervous system disorders; antiinflammatory agents
03/29/2007US20070072846 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
03/29/2007US20070072845 Process for the preparation of olanzapine form 1 useful as antipsychotic drug
03/29/2007US20070072844 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/29/2007US20070072843 Pyridyl substituted xanthines
03/29/2007US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors
03/29/2007US20070072841 Therapeutic compounds
03/29/2007US20070072840 Polymorphic forms of quetiapine
03/29/2007US20070072839 Leukemia Treatment Method and Composition
03/29/2007US20070072838 High-purity texaphyrin metal complexes
03/29/2007US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
03/29/2007US20070072836 Solid peroral contraceptive preparations
03/29/2007US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives
03/29/2007US20070072834 13-Substituted methacycline compounds
03/29/2007US20070072833 Survivin inhibitors
03/29/2007US20070072832 4-(2-Amino-5-chloro-benzoimidazol-1-yl)-2,2-dimethyl-2H-chromene-6-carbonitrile; urinary incontinence, hypertension, sexual disorders, dysmenorrhea, irritable bowl syndrome, airway hyperactivity, epilepsy, Alzheimer's and Parkinson's diseases, myocardial injury, coronary artery disease, hair loss
03/29/2007US20070072831 Integrase inhibitor compounds
03/29/2007US20070072830 Methods for treating diabetes
03/29/2007US20070072828 Bile preparations for colorectal disorders
03/29/2007US20070072826 Compositions and methods for modulation of vascular structure and/or function
03/29/2007US20070072825 Erectile dysfunction, urinary incontinence, lung disease, hyperoxia, neurodegenerative disease, liver disease, myocardial damage during cardioplegia, an inflammatory condition, a reperfusion injury, an ischemic condition, a cardiovascular disease, diabetes, cancer
03/29/2007US20070072824 Methods of reducing the severity of mucositis
03/29/2007US20070072821 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
03/29/2007US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/29/2007US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/29/2007US20070072815 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
03/29/2007US20070072814 Method and means of modulating lipid metabolism
03/29/2007US20070072813 Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives
03/29/2007US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/29/2007US20070072811 like antiinfective (bactericide, fungicide, parasiticide, viricide), and antiproliferative, antiinflammatory, and prokinetic agents; 1,2,3-triazole-oxazolidine-phenyl- derivatives; effective against strains of cells or organisms that have developed drug resistance; administering orally
03/29/2007US20070072810 Agent for treating diabetes
03/29/2007US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2
03/29/2007US20070072794 Novel genes and proteins encoded thereby
03/29/2007US20070072793 Histone hyperacetylating agents for promoting wound healing and preventing scar formation
03/29/2007US20070072792 Macrocyclic lactams and pharmaceutical use thereof
03/29/2007US20070072790 Antitumor agents
03/29/2007US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors
03/29/2007US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
03/29/2007US20070071839 Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne
03/29/2007US20070071834 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method
03/29/2007US20070071830 Method for increasing bioavailability of lipophilic bioactive compounds
03/29/2007US20070071824 Treatment of mucositis using N-acetylcysteine
03/29/2007US20070071822 Film coated tablet for improved upper gastrointestinal tract safety
1 ... 3819 3820 3821 3822 3823 3824 3825 3826 3827 3828 3829 3830 3831 3832 3833 3834 3835 3836 3837 3838 3839 ... 7860